Verified
Radius
Pharmaceuticals
Founded: 2003
Headquarters: 22 Boston Wharf Rd, Boston, MA 02210, USA
Overview
Location
Massachusetts, United States
Headquarter
22 Boston Wharf Rd, Boston, MA 02210, USA
Contact Number
1-617-551-4000
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Private Company
Website
Founded
2003
CEO
Kelly Martin
Codes
SIC Code 28,283 | NAICS Code 32,325
Annual Revenue
$230 Million
Total Funding
$830.4M
Recent Funding Amount
$350M
No of Funding Rounds
10
Founders
Dr. Joseph M. Kelly
Company Overview
Radius is a biopharmaceutical company founded in 2003 and is located in Boston, Massachusetts. The company is focused on developing therapeutics for oncology, endocrine diseases, and osteoporosis.
Top C-suite Members of Company
Connect with key decision-makers at Radius. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Scott Briggs | Chief Executive Officer | s****s@radiuspharm.com | |
| Bethany Sensenig | Head Chief Financial Officer | b****g@radiuspharm.com | |
| Robin Quadros | President | r****s@radiuspharm.com | |
| Bruce Mitlak | Chief Medical Officer | b****k@radiuspharm.com | |
| John Tavernese | Corporate Controller | j****e@radiuspharm.com | |
| Scott Briggs | Chief Executive Officer | s****s@radiuspharm.com | |
| Erika Tooman | Senior Vice President | e****n@radiuspharm.com | |
| Alice Pomponio | Vice President | a****o@radiuspharm.com | |
| Bob Valentine | Business Intelligence Vice President | b****e@radiuspharm.com | |
| Sherita Hall | Vice President | s****l@radiuspharm.com | |
| John Tavernese | Corporate Controller | j****e@radiuspharm.com |
Email Formats
Discover the email patterns used at Radius to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Radius's headquarters?
Radius is headquartered at 22 Boston Wharf Rd, Boston, MA 02210, USA.
How can I contact Radius by phone?
You can reach Radius by calling their customer support number at 1-617-551-4000.
What is the official website for Radius?
You can visit Radius's official website at www.radiuspharm.com.
How much revenue does Radius generate?
Radius reports an annual revenue of approximately $230 Million.
What is the SIC code for Radius?
The Standard Industrial Classification (SIC) code for Radius is 28,283.
What is the NAICS code for Radius?
Radius falls under the NAICS code 32,325.
How many people work at Radius?
Radius has a workforce of about 450 employees.
Which technologies are used by Radius?
Radius utilizes technologies like RSS, Open Graph, HTTP/3.
Who is the Chief Executive Officer (CEO) of Radius?
The CEO of Radius is Kelly Martin.
How can I get in touch with Radius?
To contact Radius, call 1-617-551-4000 or visit their website at www.radiuspharm.com
Is Radius a publicly traded company?
No, Radius is a private company.
How much total funding has Radius secured so far?
To date, Radius has raised $830.4M across 10 funding round(s).
Which industry is Radius part of?
Radius operates in the Pharmaceuticals, Healthcare industry.
Who are the main competitors of Radius?
Key competitors of Radius include Puma Biotechnology, Akebia Therapeutics, Atara Biotherapeutics, Corcept Therapeutics Inc
Who holds the CFO position at Radius?
Bethany Sensenig serves as the Chief Financial Officer (CFO) at Radius.
When did Radius complete its most recent funding round?
Radius latest funding round closed on Aug 25, 2022 with the amount of $350 Million
Who are the investors in Radius?
Radius is backed by 31 investors : MPM BioImpact, Oxford Bioscience Partners, Healthcare Ventures and MPM BioImpact.